10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________

FORM 10-Q

____________________

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2015
	OR
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from  to

Commission File No.: 001-16753

____________________

AMN HEALTHCARE SERVICES, INC.

(Exact Name of Registrant as Specified in Its Charter)

____________________

Delaware	06-1500476
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
12400 High Bluff Drive, Suite 100 San Diego, California	92130
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (866) 871-8519

____________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o Accelerated filer  x Non-accelerated filer  o Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   o

  No  x

As of November 4, 2015, there were 47,693,968 shares of common stock, $0.01 par value, outstanding.

TABLE OF CONTENTS

Item		Page
	PART I - FINANCIAL INFORMATION
1.	Condensed Consolidated Financial Statements (unaudited):	1
	Condensed Consolidated Balance Sheets, As of September 30, 2015 and December 31, 2014	1
	Condensed Consolidated Statements of Comprehensive Income, For the Three Months and Nine Ended September 30, 2015 and 2014	2
	Condensed Consolidated Statements of Cash Flows, For the Nine Months Ended September 30, 2015 and 2014	3
	Notes to Unaudited Condensed Consolidated Financial Statements	5
2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	13
3.	Quantitative and Qualitative Disclosures about Market Risk	20
4.	Controls and Procedures	20
	PART II - OTHER INFORMATION
1.	Legal Proceedings	21
1A.	Risk Factors	21
2.	Unregistered Sales of Equity Securities and Use of Proceeds	21
3.	Defaults Upon Senior Securities	21
4.	Mine Safety Disclosures	21
5.	Other Information	21
6.	Exhibits	22
	Signatures	23

PART I - FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

AMN HEALTHCARE SERVICES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands, except par value)

	September 30, 2015			December 31, 2014
ASSETS
Current assets:
Cash and cash equivalents	$	14,408		$	13,073
Accounts receivable, net of allowances of $7,460 and $4,515 at September 30, 2015 and December 31, 2014, respectively	248,779			186,274
Accounts receivable, subcontractor	49,521			28,443
Deferred income taxes, net	18,378			27,330
Prepaid expenses	12,818			10,350
Other current assets	25,077			17,200
Total current assets	368,981			282,670
Restricted cash, cash equivalents and investments	25,425			19,567
Fixed assets, net of accumulated depreciation of $74,460 and $68,814 at September 30, 2015 and December 31, 2014, respectively	45,407			32,880
Other assets	46,634			39,895
Goodwill	201,444			154,387
Intangible assets, net of accumulated amortization of $50,725 and $41,963 at September 30, 2015 and December 31, 2014, respectively	177,347			152,517
Total assets	$	865,238		$	681,916
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	113,152		$	78,993
Accrued compensation and benefits	88,492			67,995
Current portion of revolving credit facility	30,000			18,000
Current portion of notes payable	7,500			7,500
Deferred revenue	4,944			3,177
Other current liabilities	6,026			2,630
Total current liabilities	250,114			178,295
Revolving credit facility	45,500			—
Notes payable	131,250			136,875
Deferred income taxes, net	39,000			32,491
Other long-term liabilities	75,409			77,674
Total liabilities	541,273			425,335
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September 30, 2015 and December 31, 2014	—			—
Common stock, $0.01 par value; 200,000 shares authorized; 47,694 and 46,639 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	477			466
Additional paid-in capital	440,465			434,529
Accumulated deficit	(116,332		)	(178,058		)
Accumulated other comprehensive loss	(645		)	(356		)
Total stockholders’ equity	323,965			256,581
Total liabilities and stockholders’ equity	$	865,238		$	681,916

See accompanying notes to unaudited condensed consolidated financial statements.

1

AMN HEALTHCARE SERVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited and in thousands, except per share amounts)

	Three Months Ended September 30,					Nine Months Ended September 30,
	2015			2014		2015			2014
Revenue	$	382,859		$	264,584	$	1,060,513		$	756,378
Cost of revenue	256,850			184,278		722,954			524,957
Gross profit	126,009			80,306		337,559			231,421
Operating expenses:
Selling, general and administrative	83,098			60,319		229,377			170,553
Depreciation and amortization	5,304			4,086		15,631			11,916
Total operating expenses	88,402			64,405		245,008			182,469
Income from operations	37,607			15,901		92,551			48,952
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013			1,433		5,797			7,908
Income before income taxes	35,594			14,468		86,754			41,044
Income tax expense	1,947			5,969		25,028			17,722
Net income	$	33,647		$	8,499	$	61,726		$	23,322
Other comprehensive income (loss):
Foreign currency translation	54			75		42			29
Unrealized loss on cash flow hedge, net of income taxes	(367		)	—		(331		)	—
Other comprehensive income (loss)	(313		)	75		(289		)	29
Comprehensive income	$	33,334		$	8,574	$	61,437		$	23,351
Net income per common share:
Basic	$	0.71		$	0.18	$	1.30		$	0.50
Diluted	$	0.69		$	0.18	$	1.27		$	0.49
Weighted average common shares outstanding:
Basic	47,674			46,546		47,466			46,460
Diluted	48,978			48,122		48,737			47,959

See accompanying notes to unaudited condensed consolidated financial statements.

2

AMN HEALTHCARE SERVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)

	Nine Months Ended September 30,
	2015			2014
Cash flows from operating activities:
Net income	$	61,726		$	23,322
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions:
Depreciation and amortization	15,631			11,916
Non-cash interest expense and other	1,445			1,104
Loss on debt extinguishment	—			3,113
Change in fair value of contingent consideration	(300		)	—
Increase in allowances for doubtful accounts and sales credits	5,315			2,915
Provision for deferred income taxes	17,683			1,768
Share-based compensation	6,551			5,361
Excess tax benefits from share-based compensation	(7,269		)	(1,780		)
Loss on disposal or sale of fixed assets	3			50
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(46,732		)	(19,516		)
Accounts receivable, subcontractor	(21,078		)	(3,298		)
Income taxes receivable	1,008			484
Prepaid expenses	(2,213		)	(1,935		)
Other current assets	(6,111		)	(733		)
Other assets	(3,454		)	(188		)
Accounts payable and accrued expenses	25,808			(4,302		)
Accrued compensation and benefits	16,707			8,625
Other liabilities	(4,365		)	4,662
Deferred revenue	1,140			(37		)
Restricted cash, cash equivalents and investments balance	(5,858		)	(9,038		)
Net cash provided by operating activities	55,637			22,493
Cash flows from investing activities:
Purchase and development of fixed assets	(21,122		)	(14,287		)
Equity method investment in Pipeline Health Holdings LLC	(1,000		)	(5,000		)
Payments to fund deferred compensation plan	(2,250		)	(2,174		)
Cash paid for acquisitions, net of cash received	(81,097		)	—
Cash paid for working capital adjustments for prior year acquisition	(165		)	—
Change in restricted cash, cash equivalents and investments balance	—			11,141
Net cash used in investing activities	(105,634		)	(10,320		)
Cash flows from financing activities:
Capital lease repayments	(4		)	(472		)
Payments on term loan	(5,625		)	(153,370		)
Proceeds from term loan	—			150,000
Payments on revolving credit facility	(27,000		)	(39,500		)
Proceeds from revolving credit facility	84,500			29,500
Payment of financing costs	—			(3,488		)
Proceeds from exercise of equity awards	3,663			1,792
Cash paid for shares withheld for taxes	(11,513		)	(4,361		)
Excess tax benefits from share-based compensation	7,269			1,780
Net cash provided by (used in) financing activities	51,290			(18,119		)
Effect of exchange rate changes on cash	42			29
Net increase (decrease) in cash and cash equivalents	1,335			(5,917		)

3

	Nine Months Ended September 30,
	2015			2014
Cash and cash equivalents at beginning of period	13,073			15,580
Cash and cash equivalents at end of period	$	14,408		$	9,663
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $173 and $83 capitalized for the nine months ended September 30, 2015 and 2014, respectively)	$	4,334		$	3,687
Cash paid for income taxes	$	20,655		$	12,732
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash received	$	26,340		$	—
Goodwill	46,891			—
Intangible assets	33,592			—
Liabilities assumed	(22,526		)	—
Holdback provision	(500		)	—
Earn-out liabilities	(2,700		)	—
Net cash paid for acquisitions	$	81,097		$	—
Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses	$	2,206		$	3,751
Convertible loan converted to equity method investment in Pipeline Health Holdings LLC	$	1,000		$	—

See accompanying notes to unaudited condensed consolidated financial statements.

4

AMN HEALTHCARE SERVICES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands, except per share amounts)

1. BASIS OF PRESENTATION

The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.

The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2014, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange Commission on February 25, 2015 (“2014 Annual Report”).

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.

Reclassification

Certain reclassifications that are not material have been made to the prior year’s consolidated financial statements to conform to the current year presentation.

2. BUSINESS COMBINATIONS

The First String Healthcare Acquisition

On September 15, 2015, the Company completed its acquisition of The First String Healthcare (“TFS”), a leading provider of interim staffing and permanent placement of nurse leaders and executives. The total purchase price of $7,653 included (1) $4,453 cash consideration paid upon acquisition, funded by cash-on-hand, net of cash received, (2) $500 to be paid on the first anniversary of the acquisition date, and (3) a contingent earn-out with a fair value of $2,700 as of the acquisition date. Also, the purchase agreement included an additional $1,000 payment to be paid on the second anniversary of the acquisition date conditioned upon, subject to certain exceptions, continued employment of the selling shareholders, which will be recorded as compensation expense for post-combination services. The acquisition is intended to enhance the Company’s capabilities to provide interim and permanent nursing leadership. As the acquisition is not considered significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $4,000, of which (1) up to $1,000 may be paid to the sellers in 2016 based on the operating results of TFS for the 12-month period ending December 31, 2015 and (2) up to $3,000 may be paid in 2017 based on the operating results of TFS for the 12-month period ending December 31, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $920 of fair value of tangible assets acquired, $867 of liabilities assumed, $3,373 of identified intangible assets and $4,228 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships staffing database and covenant not to compete. The weighted average useful life of the acquired intangible assets subject to amortization is approximately seven years.

5

The results of operations of TFS are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

Onward Healthcare Acquisition

On January 7, 2015, the Company completed its acquisition of Onward Healthcare, including its two wholly-owned subsidiaries, Locum Leaders and Medefis (collectively, “OH”), for approximately $76,643 in cash, funded by cash-on-hand and borrowings under the Company’s revolving credit facility. Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a provider of a software as a service, or “SaaS,” based vendor management system for healthcare facilities. The acquisition helps the Company to expand its service lines and its supply and placement capabilities of healthcare professionals to its clients.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the $76,643 purchase price consisted of $25,420 of fair value of tangible assets acquired (including $20,269 of accounts receivable), $21,659of liabilities assumed (including $10,534 of accounts payable and accrued expenses), $30,219 of identified intangible assets, and $42,663 of goodwill, a portion of which is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships, staffing database, acquired technologies and non-compete agreements. The weighted average useful life of the acquired intangible assets is approximately 11 years. The following table summarizes the fair value and useful life of each intangible asset acquired:

		Fair Value		Useful Life
				(in years)
Identifiable intangible assets
	Tradenames and Trademarks	$	8,100	3 - 15
	Customer Relationships	17,600		10 - 15
	Staffing Database	2,600		5
	Acquired Technologies	1,700		8
	Non-compete agreements	219		2
		$	30,219

Of the $42,663 allocated to goodwill, $37,422 and $5,241 were allocated to the Company’s nurse and allied healthcare staffing segment and locum tenens staffing segment, respectively.

The results of Onward Healthcare and Medefis are included in the Company’s nurse and allied healthcare staffing segment and the results of Locum Leaders are included in the Company’s locum tenens staffing segment since the date of acquisition. For the three months ended September 30, 2015, approximately $39,145 of revenue and $4,774 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations. For the nine months ended September 30, 2015, approximately $106,492 of revenue and $11,416 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations.

The following summary presents unaudited pro forma consolidated results of operations of the Company for the three and nine months ended September 30, 2015 and 2014 as if the OH acquisition described above had occurred on January 1, 2014. The following unaudited pro forma financial information gives effect to certain adjustments, including the reduction in compensation expense related to non-recurring executive salary expense, acquisition-related costs and the amortization of acquired intangible assets. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results.

6

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue	$	382,859	$	293,072	$	1,062,798	$	838,109
Net income	$	34,350	$	9,091	$	63,513	$	24,088
Net income per common share:
Basic	$	0.72	$	0.20	$	1.34	$	0.52
Diluted	$	0.70	$	0.19	$	1.30	$	0.50

Avantas Acquisition

On December 22, 2014, the Company completed its acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology, for $17,520, which the Company funded through cash-on-hand and borrowings under its revolving credit facility. The total purchase price of $17,520 included $14,470 cash consideration paid, $1,650 cash holdback for potential working capital claims, and contingent earn-out payments with a fair value of $1,400 as of the acquisition date. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015. During the nine months ended September 30, 2015, the Company paid an additional $165 to the selling equityholders for a working capital adjustment. The acquisition is intended to help enable the Company to provide a level of workforce predictability to clients that can be integrated with its workforce and staffing solutions. As the acquisition is not significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $8,500 to be paid in 2016 based on the operating results of Avantas for the 12-month period ending June 30, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $1,631 of fair value of tangible assets acquired, $3,821 of liabilities and deferred revenue assumed, $9,960 of identified intangible assets and $9,916 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 14 years.

The results of operations of Avantas are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements.

3. REVENUE RECOGNITION

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $53,575 and $33,474 were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of September 30, 2015 and the audited consolidated balance sheet as of December 31, 2014, respectively.

4. NET INCOME PER COMMON SHARE

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.

Share-based awards to purchase 286 shares of common stock were not included in the calculation of diluted net income per common share for the three months ended September 30, 2014 because the effect of these instruments was anti-dilutive. Share-based awards to purchase 12 and 344 shares of common stock were not included in the calculation of diluted net income

7

per common share for the nine months ended September 30, 2015 and 2014, respectively, because the effect of these instruments was anti-dilutive.

The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2015 and 2014, respectively:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Net income	$	33,647	$	8,499	$	61,726	$	23,322
Net income per common share - basic	$	0.71	$	0.18	$	1.30	$	0.50
Net income per common share - diluted	$	0.69	$	0.18	$	1.27	$	0.49
Weighted average common shares outstanding - basic	47,674		46,546		47,466		46,460
Plus dilutive effect of potential common shares	1,304		1,576		1,271		1,499
Weighted average common shares outstanding - diluted	48,978		48,122		48,737		47,959

5. SEGMENT INFORMATION

The Company has three reportable segments: (1) nurse and allied healthcare staffing, (2) locum tenens staffing, and (3) physician permanent placement services.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue
Nurse and allied healthcare staffing	$	266,279	$	174,292	$	735,341	$	503,636
Locum tenens staffing	101,755		78,816		285,835		219,996
Physician permanent placement services	14,825		11,476		39,337		32,746
	$	382,859	$	264,584	$	1,060,513	$	756,378
Segment Operating Income
Nurse and allied healthcare staffing	$	40,873	$	21,279	$	108,169	$	63,283
Locum tenens staffing	13,321		8,139		34,142		22,830
Physician permanent placement services	4,555		2,756		11,103		7,074
	58,749		32,174		153,414		93,187
Unallocated corporate overhead	13,817		10,396		38,681		26,958
Depreciation and amortization	5,304		4,086		15,631		11,916
Share-based compensation	2,021		1,791		6,551		5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013		1,433		5,797		7,908
Income before income taxes	$	35,594	$	14,468	$	86,754	$	41,044

8

6. DERIVATIVE INSTRUMENTS

In April 2015, the Company entered into an interest rate swap agreement to minimize its exposure to interest rate fluctuations on $100,000 of its outstanding variable rate debt under its existing term loan facility whereby the Company pays a fixed rate of 0.983% per annum and receives a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into this agreement.

At September 30, 2015, the interest rate swap agreement had a fair value of $(542), which is included in other long-term liabilities in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2015. The Company has formally documented the hedging relationship and accounts for this arrangement as a cash flow hedge. The Company recognizes all derivatives on the balance sheet at fair value based on quotes from an independent pricing service. Gains or losses resulting from changes in the values of the arrangement are recorded in other comprehensive income (loss), net of tax, until the hedged item is recognized in earnings. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivative instrument that is used in the hedging transaction is highly effective in offsetting changes in fair values or cash flows of the hedged item. When it is determined that a derivative instrument is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively and recognizes subsequent changes in market value in earnings.

7. FAIR VALUE MEASUREMENT

The Company’s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2 and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 4 - Fair Value Measurement” of the 2014 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2015, except for the new interest rate swap agreement entered into in April 2015.

Assets and Liabilities Measured on a Recurring Basis

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

The Company’s interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap has been measured as of September 30, 2015 in accordance with Level 2 input of the fair value hierarchy using an independent pricing service, which the Company believes is an industry standard model that considers time value, current market and contractual prices for the underlying instrument, volatility factors and other relevant economic measures. The valuation also consider credit risk adjustments that are necessary to reflect the probability of default by the counterparty or the Company, which are considered Level 3 inputs; however, as of September 30, 2015, the credit risk adjustments, including nonperformance risk, were considered insignificant to the total fair value of the interest rate swaps.

The Company has an obligation to pay earn-out consideration of up to $8,500 to the selling equity holders if Avantas meets certain future financial metrics for the 12-month period ending June 30, 2016. The Company also has an obligation to pay earn-out consideration of up to $4,000 to the selling shareholders if TFS meets certain future financial metrics for calendar years 2015 and 2016. The earn-out liabilities in connection with both acquisitions were estimated based on estimated cash flows determined using the probability-weighted average of possible outcomes that would occur should certain financial metrics be reached. As there is no market data available to use in valuing the contingent consideration, the Company developed its own assumptions related to the future financial performance of Avantas and TFS to estimate the fair value of the liabilities. As such, the contingent consideration liabilities are classified within Level 3.

In connection with estimating the fair value of the contingent consideration for Avantas, the Company estimates the weighted probability of Avantas earning each of the five specified tiered earn-out amounts of $0, $1,500, $3,500, $5,500 and $8,500, which are each tied to the financial performance of Avantas for the 12-month period ending June 30, 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015.

In connection with estimating the fair value of the contingent consideration for TFS, the Company estimates the weighted probability of TFS earning each of the three specified tiered earn-out amounts of $0, $500, and $1,000, which are each tied to the financial performance of TFS for calendar year 2015 and each of the six specified tiered earn-out amounts of $0, $1,000,

9

$1,500, $2,000, $2,500 and $3,000, which are each tied to the financial performance of TFS for calendar year 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value.

The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

	Fair Value Measurements as of September 30, 2015
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds	$	5,626	$	5,626	$	—	$	—
Interest rate swap liability	542		—		542		—
Acquisition contingent consideration earn-out liabilities	3,800		—		—		3,800
Total financial assets and liabilities measured at fair value	$	9,968	$	5,626	$	542	$	3,800

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets and liabilities measured at fair value	$	7,026	$	5,626	$	—	$	1,400

Level 3 Information

The following table sets forth reconciliations of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:

	Three months ended September 30,
	2015			2014
Balance as of July 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

	Nine months ended September 30,
	2015			2014
Balance as of January 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

10

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

There were no triggering events identified and no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets or equity method investment during the nine months ended September 30, 2015 and 2014.

Fair Value of Financial Instruments

The carrying amount of the Company’s notes payable and revolving credit facility approximate their fair value as the instruments’ interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity. The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

8. INCOME TAXES

The Company is subject to income taxation in the U.S. and various states and foreign jurisdictions. As of September 30, 2015, the Company is no longer subject to U.S. federal income or payroll tax examinations before 2011. With few exceptions, as of September 30, 2015, the Company is no longer subject to state, local or foreign income tax examinations by tax authorities for tax years before 2006. The Company’s tax years 2007, 2008, 2009 and 2010 had been under audit by the Internal Revenue Service (“IRS”) for several years and, in 2014, the IRS issued the Company its Revenue Agent Report (“RAR”) and an Employment Tax Examination Report (“ETER”). The RAR proposed adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006, resulting from the proposed disallowance of certain per diems paid to the Company’s healthcare professionals, and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2009 and 2010 related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER were mutually exclusive, and contain multiple tax positions, some of which were contrary to each other. The Company filed a Protest Letter for both the RAR and ETER positions in 2014. The Company received a final determination from the IRS in July 2015 on both the RAR adjustments and ETER assessments and the federal audit was settled for $7,200 (including interest) during the third quarter of 2015. As a result, the Company recorded federal income tax benefits of approximately $12,200 during the quarter ended September 30, 2015 and expects to record the state income tax benefits of approximately $1,500 by the quarter ending December 31, 2016, when the various state statutes are projected to lapse.

The IRS had also been conducting a separate audit of the Company’s 2011 and 2012 tax years. The income and employment tax issues addressed in the 2011 and 2012 examination are consistent with the issues raised in the 2007 through 2010 examination. During the quarter ended March 31, 2015, the IRS completed its 2011 and 2012 examination and issued its RAR and ETER to the Company. The proposed adjustments to the Company’s taxable income for 2011 and 2012 and net operating loss carryforwards from 2010 and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2011 and 2012 are related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER for the 2011 and 2012 years are mutually exclusive and contain multiple tax positions, some of which are contrary to each other. The Company has filed a Protest Letter for both the RAR and ETER in April 2015. The Company intends to defend its position. The IRS began an audit of the Company’s 2013 tax year during the quarter ended June 30, 2015. The Company believes its reserves are adequate with respect to these open years.

9. COMMITMENTS AND CONTINGENCIES

(a) Legal

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of its clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. With regards to outstanding loss contingencies as of September 30, 2015, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows.

(b) Leases

On January 26, 2015, the Company entered into a 10-year operating lease agreement for office space in Dallas, Texas that replaced its current operating lease agreement for its Irving, Texas offices, which expired in August 2015. Base rent payments under the new lease agreement began in September 2015 and the total estimated base rent payments will be approximately $23,956 over the life of the lease, which is ten years. The rent payments have been included in the total minimum lease payment table set forth in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 12(b) - Commitments and Contingencies - Leases” of the Company’s 2014 Annual Report.

11

10. BALANCE SHEET DETAILS

The consolidated balance sheets detail is as follows as of September 30, 2015 and December 31, 2014:

	September 30, 2015			December 31, 2014
Other current assets:
Restricted cash	$	13,143		$	9,054
Income taxes receivable	4,195			3,503
Other	7,739			4,643
Other current assets	$	25,077		$	17,200
Fixed assets:
Furniture and equipment	$	21,158		$	17,761
Software	93,485			78,593
Leasehold improvements	5,224			5,340
	119,867			101,694
Accumulated depreciation and amortization	(74,460		)	(68,814		)
Fixed assets, net	$	45,407		$	32,880
Accounts payable and accrued expenses:
Trade accounts payable	$	48,109		$	30,039
Subcontractor payable	53,575			33,474
Professional liability reserve	7,403			7,380
Overdraft	2,548			6,338
Other	1,517			1,762
Accounts payable and accrued expenses	$	113,152		$	78,993
Accrued compensation and benefits:
Accrued payroll	$	32,569		$	21,857
Accrued bonuses	20,218			15,196
Accrued travel expense	2,868			2,413
Accrued health insurance reserve	2,517			1,871
Accrued workers compensation reserve	7,539			5,830
Deferred compensation	21,968			20,729
Other	813			99
Accrued compensation and benefits	$	88,492		$	67,995

11. SUBSEQUENT EVENTS

On October 5, 2015, the Company completed its acquisition of Millican Solutions, Inc., a physician and executive leadership search firm serving academic medical centers nationwide for $4,075 in cash. The acquisition is intended to enhance the Company’s ability to respond to the specialized leadership needs within academic pediatrics and children’s medical centers and expands the Company’s expertise in serving academic medical centers and teaching hospitals in physician and leadership search.

12

Item 2. Management’s Discussion and Analysis of Financial Condition and Results

of Operations

The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange Commission (“SEC”) on February 25, 2015 (“2014 Annual Report”). Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements.” See “Special Note Regarding Forward-Looking Statements.” We undertake no obligation to update the forward-looking statements in this Quarterly Report. References in this Quarterly Report to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries.

Overview

We are the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. As an innovative workforce solutions partner, our managed services programs, or “MSP,” vendor management systems, or “VMS,” recruitment process outsourcing, or “RPO,” workforce consulting services, predictive modeling, staff scheduling and the placement of physicians, nurses, allied healthcare professionals and healthcare executives into temporary and permanent positions enable our clients to successfully reduce staffing complexity, increase efficiency, improve patient outcomes and lead their organizations within the rapidly evolving healthcare environment. Our clients include acute and sub-acute care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and several other healthcare settings. Our clients utilize our workforce solutions and healthcare staffing services to meet their workforce needs, both temporary and permanent, in an economically beneficial manner. Our managed services program and vendor management systems enable healthcare organizations to increase their efficiency by managing all of their supplemental workforce needs through one company or technology.

We conduct business through three reportable segments: (1) nurse and allied healthcare staffing, (2) locum tenens staffing, and (3) physician permanent placement services. For the three months ended September 30, 2015, we recorded revenue of $382.9 million, as compared to $264.6 million for the same period last year. For the three months ended September 30, 2015, we recorded net income of $33.6 million, as compared to $8.5 million for the same period last year. For the nine months ended September 30, 2015, we recorded revenue of $1,060.5 million, as compared to $756.4 million for the same period last year. For the nine months ended September 30, 2015, we recorded net income of $61.7 million, as compared to $23.3 million for the same period last year.

On January 7, 2015, we completed the acquisition of Onward Healthcare, including its two wholly-owned subsidiaries, Locum Leaders and Medefis (collectively, “OH”). Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a leading provider of a software as a service, or “SaaS,” based vendor management system for healthcare facilities. The results of Onward Healthcare and Medefis are included in our nurse and allied healthcare staffing segment and the results of Locum Leaders are included in our locum tenens staffing segment, in each case since the date of acquisition. On September 15, 2015, we completed the acquisition of The First String Healthcare (“TFS”), a provider of interim staffing and permanent placement for mid- to high-level nurse leadership positions, dedicated to pairing talented healthcare managers, directors and educators with career opportunities. The results of TFS are included in our nurse and allied healthcare staffing segment since the date of acquisition. In addition, during the fourth quarter of 2014 we acquired Avantas. The results of Avantas are included in our nurse and allied healthcare staffing segment. For the three months ended September 30, 2015, approximately $42.8 million of OH, Avantas and TFS revenue and $6.0 million of OH, Avantas and TFS income before income taxes were included in the unaudited condensed consolidated statement of operations. For the nine months ended September 30, 2015, approximately $114.5 million of OH, Avantas and TFS revenue and $12.3 million of OH, Avantas and TFS income before income taxes were included in the unaudited condensed consolidated statement of operations.

Nurse and allied healthcare staffing segment revenue comprised 69% and 67% of total consolidated revenue for the nine months ended September 30, 2015 and 2014, respectively. Through our nurse and allied healthcare staffing segment, we provide hospitals and other healthcare facilities with a range of clinical workforce solutions, including: (1) a comprehensive managed services solution in which we manage and staff all of the temporary nursing and allied staffing needs of a client; (2) a SaaS VMS through which our clients can manage all of their temporary nursing and allied staffing needs; (3) traditional clinical staffing solutions of variable assignment lengths; (4) a recruitment process outsourcing program that leverages our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent placement needs; and (5) clinical labor consulting management services.

13

Locum tenens staffing segment revenue comprised 27% and 29% of total consolidated revenue for the nine months ended September 30, 2015 and 2014, respectively. Through our locum tenens staffing segment, we provide (1) a comprehensive managed services solution in which we manage all of the locum tenens needs of a client; (2) a SaaS VMS through which our clients can manage and staff all of their locum tenens needs; and (3) placement of physicians of all specialties, as well as dentists and other advanced practice providers, with clients on a temporary basis as independent contractors. These locum tenens providers are used by our healthcare facility and physician practice group clients to fill temporary vacancies created by vacation and leave schedules and to bridge the gap while they seek permanent candidates or explore expansion. Our locum tenens clients represent a diverse group of healthcare organizations throughout the United States, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions and insurance entities. The professionals we place are recruited nationwide and are typically placed on multi-week contracts with assignment lengths ranging from a few days up to one year.

Physician permanent placement services segment revenue comprised 4% of total consolidated revenue for both the nine months ended September 30, 2015 and 2014. Through our physician permanent placement services segment, we assist hospitals, healthcare facilities and physician practice groups throughout the United States in identifying and recruiting physicians and physician executives for permanent placement. Our broad specialty offerings include over 70 specialist and sub-specialist opportunities such as internal medicine, family practice and orthopedic surgery. We perform the vast majority of our services on a retained basis through our Merritt Hawkins^® brand, for which we are generally paid through a blend of retained search fees and variable fees tied to work performed and successful placement. To a smaller degree, we also perform our services on a contingent basis, exclusively through our Kendall & Davis^® brand, for which fees are paid once physician candidates are ultimately hired by our clients.

Management Initiatives

Our growth strategy focuses on providing an innovative and differentiated value and experience to our clients and healthcare professionals. To accomplish this, we offer innovative workforce solution offerings such as MSP, VMS, RPO and clinical labor management consulting in addition to temporary clinical staffing, temporary and permanent healthcare leadership and executives, and physician permanent placement services. Through these differentiated services, we have built strategic relationships with our clients to assist them in improving their financial, operational and patient care results through enhanced productivity, labor optimization and candidate quality enhancement. We continually seek strategic opportunities to expand into new workforce solutions with recurring revenue streams as well as opportunities to expand our services to encompass emerging healthcare roles. At the same time, we continue to invest in our technology infrastructure and new recruitment approaches to capitalize on the demand growth we are experiencing and expect to continue due to the impact of healthcare reform, the aging population and healthcare staffing shortages within certain regions and disciplines.

Recent Trends

The healthcare staffing environment has remained strong throughout 2015. Demand in all our staffing businesses is significantly above prior-year levels. This demand growth has translated into an increase in the number of healthcare professionals currently on assignment and increased booking levels for future assignments. On the supply side, since the beginning of 2015, we have been experiencing an increase in the number of first time travel nurses, which we believe demonstrates more willingness for healthcare professionals to work temporary assignments.

We continue to experience a high level of demand for our workforce solutions programs. Comprised of ShiftWise, Avantas and Medefis along with our MSP and RPO programs, we expect that revenue attributable to our suite of workforce solutions offerings will continue to grow. The growth in revenue from these workforce solutions offerings are contributing to our increasing gross margins. While we have increased pay rates to attract more nursing and allied healthcare professionals into our industry to meet the increased demand, the highly competitive market for supply has allowed us to negotiate increased bill rates with many of our clients to mitigate the overall gross margin impact.

We continue to experience strong demand for our services within both the locum tenens and physician permanent placement services segments that has translated into improved profitability. Within our permanent placement division, in particular, we have seen an increase in new searches from large integrated health systems, which is becoming an increasingly important part of the business in light of healthcare consolidation.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements in conformity with United States generally accepted accounting principles requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including

14

those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. We base these estimates on the information that is currently available to us and on various other assumptions that we believe are reasonable under the circumstances. Actual results could vary from these estimates under different assumptions or conditions. If these estimates differ significantly from actual results, our consolidated financial statements and future results of operations may be materially impacted. Our critical accounting policies and estimates remain consistent with those reported in our 2014 Annual Report.

Results of Operations

The following table sets forth, for the periods indicated, selected unaudited condensed consolidated statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1) nurse and allied healthcare staffing, (2) locum tenens staffing, and (3) physician permanent placement services. The OH, Avantas and TFS acquisitions impact the comparability of the results between the three and nine months ended September 30, 2015 and the three and nine months ended September 30, 2014. Our historical results are not necessarily indicative of our future results of operations.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Unaudited Condensed Consolidated Statements of Operations:
Revenue	100.0	%	100.0	%	100.0	%	100.0	%
Cost of revenue	67.1		69.6		68.2		69.4
Gross profit	32.9		30.4		31.8		30.6
Selling, general and administrative	21.7		22.8		21.6		22.5
Depreciation and amortization	1.4		1.5		1.5		1.6
Income from operations	9.8		6.1		8.7		6.5
Interest expense, net, and other	0.5		0.5		0.5		1.0
Income before income taxes	9.3		5.6		8.2		5.5
Income tax expense	0.5		2.3		2.4		2.3
Net income	8.8	%	3.3	%	5.8	%	3.2	%

Comparison of Results for the Three Months Ended September 30, 2015 to the Three Months Ended September 30, 2014

Revenue.    Revenue increased 45% to $382.9 million for the three months ended September 30, 2015 from $264.6 million for the same period in 2014, due to additional revenue of approximately $42.8 million resulting from our OH, Avantas and TFS acquisitions with the remainder of the increase driven by 29% organic growth.

Nurse and allied healthcare staffing segment revenue increased 53% to $266.3 million for the three months ended September 30, 2015 from $174.3 million for the same period in 2014. Of the $92.0 million increase, approximately $33.5 million was attributable to the additional revenue in connection with the OH, Avantas and TFS acquisitions, with the remainder primarily attributable to an over 10% increase in the average number of healthcare professionals on assignment, a 7% increase in the average bill rate, an increase in the average numbers of hours worked by our healthcare professionals, and growth in our other workforce solutions offerings during the three months ended September 30, 2015.

Locum tenens staffing segment revenue increased 29% to $101.8 million for the three months ended September 30, 2015 from $78.8 million for the same period in 2014. Of the $22.9 million increase, $9.2 million was attributable to the additional revenue in connection with the OH acquisition with the remainder primarily attributable to a 9% increase in the number of days filled and an 8% increase in revenue per day filled during the three months ended September 30, 2015.

Physician permanent placement services segment revenue increased 29% to $14.8 million for the three months ended September 30, 2015 from $11.5 million for the same period in 2014. The increase was primarily due to an increase in billable active searches and the average placement value during the three months ended September 30, 2015.

Gross Profit.    Gross profit increased 57% to $126.0 million for the three months ended September 30, 2015 from $80.3 million for the same period in 2014, representing gross margins of 32.9% and 30.4%, respectively. The increase in consolidated gross margin was due to an increase in gross margin in all three of our segments. The nurse and allied healthcare staffing

15

segment increase in gross margin was primarily due to the acquisition of the higher margin Medefis and Avantas businesses, and growth in our higher margin RPO and ShiftWise business lines during the three months ended September 30, 2015. The locum tenens staffing segment increase in gross margin was primarily due to higher bill to pay spreads during the three months ended September 30, 2015. The physician permanent placement services segment increase was primarily due to lower recruiter compensation as a percentage of revenue during the three months ended September 30, 2015. Gross margin by reportable segment for the three months ended September 30, 2015 and 2014 was 32.0% and 28.7% for nurse and allied healthcare staffing, 30.7% and 29.0% for locum tenens staffing, and 65.4% and 64.9% for physician permanent placement services, respectively.

Selling, General and Administrative Expenses.    Selling, general and administrative (“SG&A”) expenses were $83.1 million, representing 21.7% of revenue, for the three months ended September 30, 2015, as compared to $60.3 million, representing 22.8% of revenue, for the same period in 2014. The increase in SG&A expense was primarily due to $8.0 million of additional SG&A expenses from the OH, Avantas, and TFS acquisitions, as well as increased employee headcount, variable compensation, and other expenses associated with our revenue growth. SG&A expense increases in the nurse and allied healthcare staffing and locum tenens staffing segments were primarily attributable to $6.3 million and $1.5 million, respectively, of additional SG&A expenses from the acquisitions and higher expenses to support our growth. The increase in the unallocated corporate overhead was primarily attributable to higher employee and office expenses to support our growth. SG&A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows:

	(In Thousands) Three Months Ended September 30,
	2015		2014
Nurse and allied healthcare staffing	$	44,226	$	28,749
Locum tenens staffing	17,889		14,694
Physician permanent placement services	5,145		4,689
Unallocated corporate overhead	13,817		10,396
Share-based compensation	2,021		1,791
	$	83,098	$	60,319

Depreciation and Amortization Expenses.    Amortization expense increased 58% to $3.0 million for the three months ended September 30, 2015 from $1.9 million for the same period in 2014, primarily attributable to additional amortization expense related to the intangible assets acquired in the OH, Avantas and TFS acquisitions. Depreciation expense increased 10% to $2.3 million for the three months ended September 30, 2015 from $2.1 million for the same period in 2014, primarily attributable to fixed assets acquired as part of the OH, Avantas and TFS acquisitions and an increase in purchased and developed hardware and software placed in service for our ongoing front and back office information technology initiatives.

Interest Expense, Net, and Other.    Interest expense, net, and other, was $2.0 million during the three months ended September 30, 2015 and $1.4 million during the three months ended September 30, 2014. The increase is primarily due to a higher average debt outstanding balance for the three months ended September 30, 2015, which resulted from our borrowings used to finance the OH acquisition. In addition, there were $0.2 million of losses on equity method investment for each of the three months ended September 30, 2015 and 2014.

Income Tax Expense.    Income tax expense was $1.9 million for the three months ended September 30, 2015 as compared to income tax expense of $6.0 million for the same period in 2014, reflecting effective income tax rates of 5% and 41% for the three months ended September 30, 2015 and 2014, respectively. During the three months ended September 30, 2015, we recorded a discrete federal income tax benefit of $12.2 million resulting from the IRS federal audit settlement. See additional information in “Item 1. Condensed Consolidated Financial Statements - Notes to Unaudited Condensed Consolidated Financial Statements - Note (8), Income Taxes.” We currently estimate our annual effective income tax rate to be approximately 33% for 2015.

Comparison of Results for the Nine Months Ended September 30, 2015 to the Nine Months Ended September 30, 2014

Revenue.    Revenue increased 40% to $1,060.5 million for the nine months ended September 30, 2015 from $756.4 million for the same period in 2014, due to additional revenue of approximately $114.5 million resulting from our OH, Avantas and TFS acquisitions with the remainder of the increase driven by 25% organic growth.

16

Nurse and allied healthcare staffing segment revenue increased 46% to $735.3 million for the nine months ended September 30, 2015 from $503.6 million for the same period in 2014. Of the $231.7 million increase, $89.4 million was attributable to the additional revenue in connection with the OH, Avantas and TFS acquisitions, with the remainder primarily attributable to an over 10% increase in the average number of healthcare professionals on assignment, a 7% increase in the average bill rate, an increase in the average numbers of hours worked by our healthcare professionals, and growth in our other workforce solutions offerings during the nine months ended September 30, 2015.

Locum tenens staffing segment revenue increased 30% to $285.8 million for the nine months ended September 30, 2015 from $220.0 million for the same period in 2014. Of the $65.8 million increase, $25.1 million was attributable to the additional revenue in connection with the OH acquisition with the remainder primarily attributable to an 11% increase in the number of days filled and a 7% increase in revenue per day filled during the nine months ended September 30, 2015.

Physician permanent placement services segment revenue increased 20% to $39.3 million for the nine months ended September 30, 2015 from $32.7 million for the same period in 2014. The increase was primarily due to an increase in billable active searches and placements during the nine months ended September 30, 2015.

Gross Profit.    Gross profit increased 46% to $337.6 million for the nine months ended September 30, 2015 from $231.4 million for the same period in 2014, representing gross margins of 31.8% and 30.6%, respectively. The increase in consolidated gross margin was due to an increase in gross margin in all three of our segments. The nurse and allied healthcare staffing segment increase in gross margin was primarily due to the acquisition of the higher margin Medefis and Avantas businesses, and growth in our higher margin RPO and ShiftWise business lines during the nine months ended September 30, 2015. The locum tenens staffing segment increase was primarily due to higher bill to pay spreads during the nine months ended September 30, 2015. The physician permanent placement services segment increase was primarily due to lower recruiter compensation as a percentage of revenue during the nine months ended September 30, 2015. Gross margin by reportable segment for the nine months ended September 30, 2015 and 2014 was 30.9% and 28.9% for nurse and allied healthcare staffing, 29.8% and 29.5% for locum tenens staffing, and 64.8% and 63.8% for physician permanent placement services, respectively.

Selling, General and Administrative Expenses.    SG&A expenses were $229.4 million, representing 21.6% of revenue, for the nine months ended September 30, 2015, as compared to $170.6 million, representing 22.5% of revenue, for the same period in 2014. The increase in SG&A expenses was primarily due to $22.9 million of additional SG&A expenses from the OH, Avantas and TFS acquisitions, $3.6 million of acquisition and integration costs, and higher expenses to support our growth. SG&A expense increases in the nurse and allied healthcare staffing and locum tenens staffing segments were primarily attributable to $17.6 million and $4.5 million, respectively, of additional SG&A expenses from the acquisitions and higher expenses to support the growth. The increase in unallocated corporate overhead was primarily attributable to $3.6 million of acquisition and integration costs, and higher employee and other expenses to support our growth. SG&A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows:

	(In Thousands) Nine Months Ended September 30,
	2015		2014
Nurse and allied healthcare staffing	$	118,743	$	82,325
Locum tenens staffing	51,030		42,078
Physician permanent placement services	14,372		13,831
Unallocated corporate overhead	38,681		26,958
Share-based compensation	6,551		5,361
	$	229,377	$	170,553

Depreciation and Amortization Expenses.    Amortization expense increased 53% to $8.7 million for the nine months ended September 30, 2015 from $5.7 million for the same period in 2014, primarily attributable to additional amortization expense related to the intangible assets acquired in the OH, Avantas and TFS acquisitions. Depreciation expense increased 11% to $6.9 million for the nine months ended September 30, 2015 from $6.2 million for the same period in 2014, primarily attributable to fixed assets acquired as part of the OH, Avantas and TFS acquisitions and an increase in purchased and developed hardware and software placed in service for our ongoing front and back office information technology initiatives.

Interest Expense, Net, and Other.    Interest expense, net, and other, was $5.8 million during the nine months ended September 30, 2015 and $7.9 million for the same period in 2014. The decrease is primarily due to a $3.1 million write-off of unamortized deferred financing fees and original issue discount in connection with the refinancing of our credit facilities that we entered into on April 18, 2014, partially offset by a higher average debt outstanding balance for the nine months ended

17

September 30, 2015, which resulted from our borrowings used to finance the OH acquisition. In addition, there were $0.7 million and $0.4 million of losses on equity method investment for the nine months ended September 30, 2015 and 2014, respectively.

Income Tax Expense.    Income tax expense was $25.0 million for the nine months ended September 30, 2015 as compared to income tax expense of $17.7 million for the same period in 2014, reflecting effective income tax rates of 29% and 43% for these periods, respectively. During the nine months ended September 30, 2015, we recorded a discrete federal income tax benefit of $12.2 million resulting from the IRS federal audit settlement. See additional information in “Item 1. Condensed Consolidated Financial Statements - Notes to Unaudited Condensed Consolidated Financial Statements - Note (8), Income Taxes.” We currently estimate our annual effective income tax rate to be approximately 33% for 2015.

Liquidity and Capital Resources

In summary, our cash flows were:

	(In Thousands) Nine Months Ended September 30,
	2015			2014
Net cash provided by operating activities	$	55,637		$	22,493
Net cash used in investing activities	(105,634		)	(10,320		)
Net cash provided by (used in) financing activities	51,290			(18,119		)

Historically, our primary liquidity requirements have been for acquisitions, working capital requirements and debt service under our credit facilities. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. We are an obligor under a term loan and we maintain a revolving credit facility. At September 30, 2015, $138.8 million of our term loan was outstanding and $75.5 million was drawn under our revolving credit facility, with $140.1 million of available credit under our revolving credit facility. We describe in further detail our credit agreement under which our term loan and revolving credit facility are governed in “Item 8. Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note (8), Notes Payable and Related Credit Agreement” of our 2014 Annual Report.

In April 2015, we entered into an interest rate swap agreement to minimize our exposure to interest rate fluctuations on $100 million of our outstanding variable rate debt under our term debt facility for which we pay a fixed rate of 0.983% per annum and receive a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into this agreement.

We believe that cash generated from operations and available borrowings under our revolving credit facility will be sufficient to fund our operations for the next 12 months and beyond. We intend to finance potential future acquisitions either with cash provided from operations, borrowings under our revolving credit facility, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.

Operating Activities

Net cash provided by operating activities for the nine months ended September 30, 2015 was $55.6 million, compared to $22.5 million for the same period in 2014. The increase in net cash provided by operating activities was primarily attributable to better operating results and an increase in accounts payable and accrued expenses (including subcontractor payable) between periods due to timing of payments. The increases were partially offset by increases in accounts receivable and accounts receivable for subcontractors and income tax payment in conjunction with the settlement of an IRS audit. Our Days Sales Outstanding was 60 days at September 30, 2015, 61 days at December 31, 2014, and 57 days at September 30, 2014.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2015 was $105.6 million, compared to $10.3 million for the same period in 2014. The increase was primarily due to $81.1 million used for the acquisitions of OH and TFS in January 2015 and September 2015, respectively. Capital expenditures were $21.1 million and $14.3 million for the nine months ended September 30, 2015 and 2014, respectively. The increase in capital expenditures was primarily to support growth in our business, our initiative to enhance our ongoing front and back office information technology platforms, including PeopleSoft and Salesforce, and our enhancement to OH, Avantas and TFS technology infrastructures.

18

Financing Activities

Net cash provided by financing activities during the nine months ended September 30, 2015 was $51.3 million, primarily due to borrowings under our revolving credit facility to fund our OH acquisition, partially offset by repayment of $5.6 million under our term loan and $27 million under our revolving credit facility and cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards. Net cash used in financing activities during the nine months ended September 30, 2014 was $18.1 million, primarily due to repayments of our debt, including both regularly scheduled payments and paying off our prior credit facilities, and cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards, partially offset by the borrowings under our current credit facilities.

Excluding the effects of the interest rate swap on our term loan facility, the annual interest rate for amounts outstanding under both our term loan and revolving credit facilities was 1.94% on a LIBOR basis as of September 30, 2015.

Letters of Credit

At September 30, 2015, we maintained outstanding standby letters of credit totaling $15.0 million as collateral in relation to our professional liability insurance agreements, workers’ compensation insurance agreements, and a corporate office lease agreement. Of the $15.0 million of outstanding letters of credit, we have collateralized $5.6 million in cash, cash equivalents and investments and the remaining amounts are collateralized by our revolving credit facility. Outstanding standby letters of credit at December 31, 2014 totaled $15.0 million.

Off-Balance Sheet Arrangements

At September 30, 2015, we did not have any off-balance sheet arrangement that has or is reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Contractual Obligations

There have been no material changes to the table entitled “Contractual Obligations” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our 2014 Annual Report that have occurred during the nine months ended September 30, 2015 with the exception of an increase of approximately $57.5 million in the amount outstanding under our revolving credit facility, which resulted from our borrowings used to finance the OH acquisition. As of September 30, 2015, the total amount outstanding under our revolving credit facility was $75.5 million. Of this amount, $30 million was classified as current at September 30, 2015, based on management intentions to repay this amount during the next 12 months. The maturity date of our revolving credit facility is in 2019.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance provides that the standard will be effective for us beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. In July 2015, the FASB voted to amend the guidance by approving a one-year delay in the effective date of the new standard to 2018. Under this deferred implementation, early adoption is allowed, but not earlier than the original effective date. We are currently evaluating the timing of its adoption and the effect that adopting this new standard will have on our financial statements and related disclosures.

In April 2015, the FASB issued ASU 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.” The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015 and early adoption is permitted. The adoption will not have a material effect on our consolidated financial statements as it will only result in a reclassification of our capitalized loan costs from other long-term assets to offset our debt balance.

In April 2015, the FASB issued ASU 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement.” This standard provides guidance about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the software license element of the arrangement should be accounted for by the customer consistent with the

acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. ASU 2015-05 is effective for fiscal years beginning after December 15, 2015, and interim periods within those years. This standard can be adopted either prospectively to all arrangements entered into or materially modified after the effective date or retrospectively. We are currently evaluating the effect that adopting this new standard will have on our financial statements and related disclosures.

In September 2015, the FASB issued ASU 2015-16, “Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.” This standard requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The standard requires that the acquirer record, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The standard also requires an entity to present separately on the face of the income statement or disclose in the notes the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. ASU 2015-16 is effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those years. We do not expect the adoption will have a material effect on our consolidated financial statements.

There have been no other new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.

Special Note Regarding Forward-Looking Statements

This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We based these forward-looking statements on our expectations, estimates, forecasts and projections about future events and about the industry in which we operate. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “should,” “would,” “project,” “may,” variations of such words and other similar expressions. In addition, any statements that refer to projections of financial items, anticipated growth, future growth and revenues, future economic conditions and performance, plans, objectives and strategies for future operations, expectations, or other characterizations of future events or circumstances are forward-looking statements. All forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ materially from those implied by the forward-looking statements in this Quarterly Report are set forth in our 2014 Annual Report and include but are not limited to:

• the effects of economic downturns or slow recoveries, which could result in less demand for our services;

• any inability on our part to maintain existing and secure new contracts directly with our clients or through group purchasing organizations;

• the level of consolidation and concentration of buyers of healthcare workforce solutions and staffing services, which could affect the pricing of our services and our ability to mitigate risk;

• any inability on our part to quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement or client needs;

• the ability of our clients to retain and increase the productivity of their permanent staff, or their ability to increase the efficiency and effectiveness of their internal recruiting efforts, through online recruiting or otherwise, which may negatively affect the demand for our services;

• our ability to grow and operate our business profitably in compliance with federal and state healthcare industry regulation including conduct of operations, and costs and payment for services and payment for referrals as well as laws regarding employment practices and government contracting;

• any significant negative effects on our business arising from federal legislation, including the Patient Protection and Affordable Care Act of 2010, regarding the current delivery and third-party payor system for healthcare;

• the challenge to the classification of certain of our healthcare professionals as independent contractors, which could adversely affect our profitability;

• the effect of medical malpractice, employment and wage regulation and other claims asserted against us, which could subject us to substantial liabilities;

• any inability on our part to safely secure private information, which could subject us to substantial liabilities;

19

• any inability on our part to implement new infrastructure and technology systems effectively, which may adversely affect our operating results and our ability to manage our business effectively;

• the effect of technology disruptions and obsolescence, which may negatively affect our business operations;

• any inability on our part to recruit and retain sufficient quality healthcare professionals at reasonable costs;

• any inability on our part to properly screen and match healthcare professionals with suitable placements;

• any inability on our part to successfully attract and retain a sufficient number of quality sales and operational personnel;

• the loss of our key officers and management personnel;

• any inability on our part to maintain our positive brand awareness and identity;

• any recognition by us of an impairment to goodwill or indefinite-lived intangibles;

• the effect of significant adverse adjustments by us to our tax and insurance-related accruals, which could decrease our earnings or increase our losses, as the case may be, or negatively affect our cash flow; and

• our level of indebtedness and any inability on our part to generate sufficient cash flow to service our debt.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. During the nine months ended September 30, 2015, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments. In April 2015, we entered into an interest rate swap agreement to minimize our exposure to interest rate fluctuations on $100 million of our outstanding variable rate debt under our term debt facility for which we pay a fixed rate of 0.983% per annum and receive a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into it. A 100 basis point increase in interest rates on our variable rate debt would not have resulted in a material effect on our unaudited condensed consolidated financial statements for the nine months ended September 30, 2015.

Item 4. Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of September 30, 2015 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

20

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

We do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2014 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

21

Item 6. Exhibits

Exhibit Number	Description
31.1	Certification by Susan R. Salka pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
31.2	Certification by Brian M. Scott pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*
32.1	Certification by Susan R. Salka pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2	Certification by Brian M. Scott pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS	XBRL Instance Document.*
101.SCH	XBRL Taxonomy Extension Schema Document.*
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.*

* Filed herewith.

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 6, 2015

AMN HEALTHCARE SERVICES, INC.

/S/    SUSAN R. SALKA

Susan R. Salka

President and Chief Executive Officer

(Principal Executive Officer)

Date: November 6, 2015

/S/    BRIAN M. SCOTT

Brian M. Scott

Chief Accounting Officer,

Chief Financial Officer and Treasurer

(Principal Accounting and Financial Officer)

23

EX-31.1

Exhibit 31.1

Certification Pursuant To

Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Susan R. Salka, certify that:

1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    SUSAN R. SALKA

Susan R. Salka

Director, President and Chief Executive Officer

(Principal Executive Officer)

Date: November 6, 2015

EX-31.2

Exhibit 31.2

Certification Pursuant To

Rule 13a-14(a) of the Securities Exchange Act of 1934

I, Brian M. Scott, certify that:

1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/S/    BRIAN M. SCOTT

Brian M. Scott

Chief Accounting Officer,

Chief Financial Officer and Treasurer

(Principal Accounting and Financial Officer)

Date: November 6, 2015

EX-32.1

Exhibit 32.1

AMN Healthcare Services, Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Susan R. Salka, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/    SUSAN R. SALKA

Susan R. Salka
Director, President and Chief Executive Officer
(Principal Executive Officer)

Date: November 6, 2015

EX-32.2

Exhibit 32.2

AMN Healthcare Services, Inc.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian M. Scott, Chief Accounting Officer, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/S/    BRIAN M. SCOTT

Brian M. Scott
Chief Accounting Officer,
Chief Financial Officer and Treasurer
(Principal Accounting and Financial Officer)

Date: November 6, 2015

XML

Income Taxes (Details) - USD ($) $ in Thousands	1 Months Ended
	Jul. 31, 2015	Dec. 31, 2016	Sep. 30, 2015
Federal Tax Authority [Member]
Income Tax Examination [Line Items]
Income tax benefits to be recorded in connection with settlement			$ 12,200
Federal Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Income Tax Examination [Line Items]
Tax settlement amount	$ 7,200
Scenario, Forecast [Member] | State Jurisdiction [Member]
Income Tax Examination [Line Items]
Income tax benefits to be recorded in connection with settlement		$ 1,500

XML

Business Combinations (Details)						3 Months Ended		9 Months Ended
	Sep. 15, 2017 USD ($)	Sep. 15, 2016 USD ($)	Sep. 15, 2015 USD ($)	Jan. 07, 2015 USD ($) subsidiary	Dec. 22, 2014 USD ($)	Sep. 30, 2015 USD ($) $ / shares	Sep. 30, 2014 USD ($) $ / shares	Sep. 30, 2015 USD ($) $ / shares	Sep. 30, 2014 USD ($) $ / shares	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2014 USD ($)
Business Combination, Description
Additional cash paid for working capital adjustment settlement								$ 165,000	$ 0
Allocation of Purchase Price
Goodwill						$ 201,444,000		201,444,000				$ 154,387,000
The First String Healthcare Acquisition [Member]
Business Combination, Description
Total purchase price of the acquisition			$ 7,653,000
Cash consideration			4,453,000
Fair value of contingent earn-out			2,700,000
Contingent earn-out based on future operating performance			4,000,000
Allocation of Purchase Price
Fair value of assets acquired			920,000
Liabilities assumed			867,000
Identified intangible assets			3,373,000
Goodwill			$ 4,228,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets			7 years
The First String Healthcare Acquisition [Member] | Scenario, Forecast [Member]
Business Combination, Description
Cash consideration		$ 500,000
Contingent earn-out future payments	$ 1,000,000
The First String Healthcare Acquisition [Member] | Scenario, Forecast [Member] | Earn-Out Payment, Payable in 2016 Based on TFS Results in 2015 [Member]
Business Combination, Description
Contingent earn-out based on future operating performance											$ 1,000,000
The First String Healthcare Acquisition [Member] | Scenario, Forecast [Member] | Earn-Out Payment, Payable in 2017 Based on TFS Results in 2016 [Member]
Business Combination, Description
Contingent earn-out based on future operating performance										$ 3,000,000
Onward Healthcare Acquisition [Member]
Business Combination, Description
Cash consideration				$ 76,643,000
Number of subsidiaries acquired with parent | subsidiary				2
Allocation of Purchase Price
Fair value of assets acquired				$ 25,420,000
Liabilities assumed				21,659,000
Identified intangible assets				30,219,000
Goodwill				42,663,000
Accounts receivable acquired				20,269,000
Accounts payable assumed				$ 10,534,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets				11 years
Business Acquisition, Pro Forma Information [Abstract]
Actual acquiree revenue since date of acquisition						39,145,000		106,492,000
Actual acquiree income before income taxes since date of acquisition						4,774,000		11,416,000
Pro forma revenue						382,859,000	$ 293,072,000	1,062,798,000	838,109,000
Pro forma net income						$ 34,350,000	$ 9,091,000	$ 63,513,000	$ 24,088,000
Net income per common share, basic (in dollars per share) | $ / shares						$ 0.72	$ 0.20	$ 1.34	$ 0.52
Net income per common share, diluted (in dollars per share) | $ / shares						$ 0.70	$ 0.19	$ 1.30	$ 0.50
Onward Healthcare Acquisition [Member] | Nurse and allied healthcare staffing [Member]
Allocation of Purchase Price
Goodwill				$ 37,422,000
Onward Healthcare Acquisition [Member] | Locum tenens staffing [Member]
Allocation of Purchase Price
Goodwill				5,241,000
Onward Healthcare Acquisition [Member] | Tradenames and trademarks [Member]
Allocation of Purchase Price
Identified intangible assets				8,100,000
Onward Healthcare Acquisition [Member] | Customer relationships [Member]
Allocation of Purchase Price
Identified intangible assets				17,600,000
Onward Healthcare Acquisition [Member] | Staffing database [Member]
Allocation of Purchase Price
Identified intangible assets				$ 2,600,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				5 years
Onward Healthcare Acquisition [Member] | Technologies [Member]
Allocation of Purchase Price
Identified intangible assets				$ 1,700,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				8 years
Onward Healthcare Acquisition [Member] | Noncompete agreements [Member]
Allocation of Purchase Price
Identified intangible assets				$ 219,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				2 years
Onward Healthcare Acquisition [Member] | Minimum [Member] | Tradenames and trademarks [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				3 years
Onward Healthcare Acquisition [Member] | Minimum [Member] | Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				10 years
Onward Healthcare Acquisition [Member] | Maximum [Member] | Tradenames and trademarks [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				15 years
Onward Healthcare Acquisition [Member] | Maximum [Member] | Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				15 years
Avantas Acquisition [Member]
Business Combination, Description
Total purchase price of the acquisition					$ 17,520,000
Cash consideration					14,470,000
Fair value of contingent earn-out						$ 1,100,000		$ 1,100,000
Contingent earn-out based on future operating performance					8,500,000
Cash holdback for potential claims					1,650,000
Contingent earn-out					1,400,000	1,100,000		1,100,000
Additional cash paid for working capital adjustment settlement					165,000
Allocation of Purchase Price
Fair value of assets acquired					1,631,000
Liabilities assumed					3,821,000
Identified intangible assets					9,960,000
Goodwill					$ 9,916,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets					14 years
Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member]
Business Combination, Description
Decrease in operating expenses						(300,000)	$ 0	$ (300,000)	$ 0
Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member] | Avantas Acquisition [Member]
Business Combination, Description
Decrease in operating expenses						$ (300,000)

XML

Business Combinations

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS

The First String Healthcare Acquisition

On September 15, 2015, the Company completed its acquisition of The First String Healthcare (“TFS”), a leading provider of interim staffing and permanent placement of nurse leaders and executives. The total purchase price of $7,653 included (1) $4,453 cash consideration paid upon acquisition, funded by cash-on-hand, net of cash received, (2) $500 to be paid on the first anniversary of the acquisition date, and (3) a contingent earn-out with a fair value of $2,700 as of the acquisition date. Also, the purchase agreement included an additional $1,000 payment to be paid on the second anniversary of the acquisition date conditioned upon, subject to certain exceptions, continued employment of the selling shareholders, which will be recorded as compensation expense for post-combination services. The acquisition is intended to enhance the Company’s capabilities to provide interim and permanent nursing leadership. As the acquisition is not considered significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $4,000, of which (1) up to $1,000 may be paid to the sellers in 2016 based on the operating results of TFS for the 12-month period ending December 31, 2015 and (2) up to $3,000 may be paid in 2017 based on the operating results of TFS for the 12-month period ending December 31, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $920 of fair value of tangible assets acquired, $867 of liabilities assumed, $3,373 of identified intangible assets and $4,228 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships staffing database and covenant not to compete. The weighted average useful life of the acquired intangible assets subject to amortization is approximately seven years.

The results of operations of TFS are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

Onward Healthcare Acquisition

On January 7, 2015, the Company completed its acquisition of Onward Healthcare, including its two wholly-owned subsidiaries, Locum Leaders and Medefis (collectively, “OH”), for approximately $76,643 in cash, funded by cash-on-hand and borrowings under the Company’s revolving credit facility. Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a provider of a software as a service, or “SaaS,” based vendor management system for healthcare facilities. The acquisition helps the Company to expand its service lines and its supply and placement capabilities of healthcare professionals to its clients.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the $76,643 purchase price consisted of $25,420 of fair value of tangible assets acquired (including $20,269 of accounts receivable), $21,659of liabilities assumed (including $10,534 of accounts payable and accrued expenses), $30,219 of identified intangible assets, and $42,663 of goodwill, a portion of which is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships, staffing database, acquired technologies and non-compete agreements. The weighted average useful life of the acquired intangible assets is approximately 11 years. The following table summarizes the fair value and useful life of each intangible asset acquired:

		Fair Value		Useful Life
				(in years)
Identifiable intangible assets
	Tradenames and Trademarks	$	8,100	3 - 15
	Customer Relationships	17,600		10 - 15
	Staffing Database	2,600		5
	Acquired Technologies	1,700		8
	Non-compete agreements	219		2
		$	30,219

Of the $42,663 allocated to goodwill, $37,422 and $5,241 were allocated to the Company’s nurse and allied healthcare staffing segment and locum tenens staffing segment, respectively.

The results of Onward Healthcare and Medefis are included in the Company’s nurse and allied healthcare staffing segment and the results of Locum Leaders are included in the Company’s locum tenens staffing segment since the date of acquisition. For the three months ended September 30, 2015, approximately $39,145 of revenue and $4,774 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations. For the nine months ended September 30, 2015, approximately $106,492 of revenue and $11,416 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations.

The following summary presents unaudited pro forma consolidated results of operations of the Company for the three and nine months ended September 30, 2015 and 2014 as if the OH acquisition described above had occurred on January 1, 2014. The following unaudited pro forma financial information gives effect to certain adjustments, including the reduction in compensation expense related to non-recurring executive salary expense, acquisition-related costs and the amortization of acquired intangible assets. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue	$	382,859	$	293,072	$	1,062,798	$	838,109
Net income	$	34,350	$	9,091	$	63,513	$	24,088
Net income per common share:
Basic	$	0.72	$	0.20	$	1.34	$	0.52
Diluted	$	0.70	$	0.19	$	1.30	$	0.50

Avantas Acquisition

On December 22, 2014, the Company completed its acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology, for $17,520, which the Company funded through cash-on-hand and borrowings under its revolving credit facility. The total purchase price of $17,520 included $14,470 cash consideration paid, $1,650 cash holdback for potential working capital claims, and contingent earn-out payments with a fair value of $1,400 as of the acquisition date. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015. During the nine months ended September 30, 2015, the Company paid an additional $165 to the selling equityholders for a working capital adjustment. The acquisition is intended to help enable the Company to provide a level of workforce predictability to clients that can be integrated with its workforce and staffing solutions. As the acquisition is not significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $8,500 to be paid in 2016 based on the operating results of Avantas for the 12-month period ending June 30, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $1,631 of fair value of tangible assets acquired, $3,821 of liabilities and deferred revenue assumed, $9,960 of identified intangible assets and $9,916 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 14 years.

The results of operations of Avantas are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements.

XML

Derivative Instruments (Details) - Interest Rate Swap [Member] - Designated as Hedging Instrument [Member] - USD ($)	Sep. 30, 2015	Apr. 30, 2015
Derivative [Line Items]
Interest rate swap, face amount		$ 100,000,000
Fixed rate on interest rate swap, percent		0.983%
Other Assets [Member]
Derivative [Line Items]
Fair value of interest rate swap	$ (542,000)

XML

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) segment	Sep. 30, 2014 USD ($)
Segment Reporting [Abstract]
Reportable business segments | segment			3
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	$ 382,859	$ 264,584	$ 1,060,513	$ 756,378
Operating Income	37,607	15,901	92,551	48,952
Depreciation and amortization	5,304	4,086	15,631	11,916
Share-based compensation	2,021	1,791	6,551	5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013	1,433	5,797	7,908
Income before income taxes	35,594	14,468	86,754	41,044
Loss on debt extinguishment		0	0	3,113
Operating segments [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	382,859	264,584	1,060,513	756,378
Operating Income	58,749	32,174	153,414	93,187
Operating segments [Member] | Nurse and allied healthcare staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	266,279	174,292	735,341	503,636
Operating Income	40,873	21,279	108,169	63,283
Operating segments [Member] | Locum tenens staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	101,755	78,816	285,835	219,996
Operating Income	13,321	8,139	34,142	22,830
Operating segments [Member] | Physician permanent placement services [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	14,825	11,476	39,337	32,746
Operating Income	4,555	2,756	11,103	7,074
Corporate, non-segment [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Unallocated corporate overhead	$ 13,817	$ 10,396	$ 38,681	$ 26,958

XML

Fair Value Measurement - Textual (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) tier	Sep. 30, 2014 USD ($)	Sep. 15, 2015 USD ($)	Dec. 22, 2014 USD ($)
Avantas Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance						$ 8,500,000
Contingent earn-out	$ 1,100,000		$ 1,100,000
The First String Healthcare Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance					$ 4,000,000
Contingent earn-out					$ 2,700,000
Contingent Consideration [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Decrease in operating expenses	(300,000)	$ 0	$ (300,000)	$ 0
Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers | tier			5
Decrease in operating expenses	(300,000)
Financial Performance Of Calendar Year 2015 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers | tier			3
Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers | tier			6
Earn-out Tier 1 [Member] | Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		$ 0
Earn-out Tier 1 [Member] | Financial Performance Of Calendar Year 2015 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		0
Earn-out Tier 1 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		0
Earn-out Tier 2 [Member] | Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,500,000		1,500,000
Earn-out Tier 2 [Member] | Financial Performance Of Calendar Year 2015 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	500,000		500,000
Earn-out Tier 2 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,000,000		1,000,000
Earn-out Tier 3 [Member] | Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	3,500,000		3,500,000
Earn-out Tier 3 [Member] | Financial Performance Of Calendar Year 2015 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,000,000		1,000,000
Earn-out Tier 3 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,500,000		1,500,000
Earn-out Tier 4 [Member] | Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	5,500,000		5,500,000
Earn-out Tier 4 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	2,000,000		2,000,000
Earn-out Tier 5 [Member] | Contingent Consideration [Member] | Avantas Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	8,500,000		8,500,000
Earn-out Tier 5 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	2,500,000		2,500,000
Earn-out Tier 6 [Member] | Financial Performance Of Calendar Year 2016 [Member] | Contingent Consideration [Member] | The First String Healthcare Acquisition [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	$ 3,000,000		$ 3,000,000

XML

Fair Value Measurement - Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	$ 9,968	$ 7,026
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	5,626
Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	542	0
Significant Unobservable Inputs (Level 3) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	1,400
Securities (Assets) [Member] | US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		5,291
Securities (Assets) [Member] | Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	335
Securities (Assets) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		5,291
Securities (Assets) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	335
Securities (Assets) [Member] | Significant Other Observable Inputs (Level 2) [Member] | US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		0
Securities (Assets) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Securities (Assets) [Member] | Significant Unobservable Inputs (Level 3) [Member] | US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		0
Securities (Assets) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	1,400
Contingent Consideration [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member] | Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member] | Significant Unobservable Inputs (Level 3) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	$ 1,400
Interest Rate Swap [Member] | Derivative Financial Instruments, Assets [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	542
Interest Rate Swap [Member] | Derivative Financial Instruments, Assets [Member] | Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	$ 542

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.

The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2014, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange Commission on February 25, 2015 (“2014 Annual Report”).

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.

Reclassification

Certain reclassifications that are not material have been made to the prior year’s consolidated financial statements to conform to the current year presentation.

XML

Fair Value Measurement Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) - Fair Value, Inputs, Level 3 [Member] - Contingent Consideration [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 1,400	$ 0	$ 1,400	$ 0
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300)	0	(300)	0
Additional contingent consideration earn-out liability from TFS acquisition	2,700	0	2,700	0
Ending balance	$ 3,800	$ 0	$ 3,800	$ 0

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 14,408	$ 13,073
Accounts receivable, net of allowances of $7,460 and $4,515 at September 30, 2015 and December 31, 2014, respectively	248,779	186,274
Accounts receivable, subcontractor	49,521	28,443
Deferred income taxes, net	18,378	27,330
Prepaid expenses	12,818	10,350
Other current assets	25,077	17,200
Total current assets	368,981	282,670
Restricted cash, cash equivalents and investments	25,425	19,567
Fixed assets, net of accumulated depreciation of $74,460 and $68,814 at September 30, 2015 and December 31, 2014, respectively	45,407	32,880
Other assets	46,634	39,895
Goodwill	201,444	154,387
Intangible assets, net of accumulated amortization of $50,725 and $41,963 at September 30, 2015 and December 31, 2014, respectively	177,347	152,517
Total assets	865,238	681,916
Current liabilities:
Accounts payable and accrued expenses	113,152	78,993
Accrued compensation and benefits	88,492	67,995
Current portion of revolving credit facility	30,000	18,000
Current portion of notes payable	7,500	7,500
Deferred revenue	4,944	3,177
Other current liabilities	6,026	2,630
Total current liabilities	250,114	178,295
Revolving credit facility	45,500	0
Notes payable	131,250	136,875
Deferred income taxes, net	39,000	32,491
Other long-term liabilities	75,409	77,674
Total liabilities	$ 541,273	$ 425,335
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September 30, 2015 and December 31, 2014	$ 0	$ 0
Common stock, $0.01 par value; 200,000 shares authorized; 47,694 and 46,639 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	477	466
Additional paid-in capital	440,465	434,529
Accumulated deficit	(116,332)	(178,058)
Accumulated other comprehensive loss	(645)	(356)
Total stockholders’ equity	323,965	256,581
Total liabilities and stockholders’ equity	$ 865,238	$ 681,916

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 61,726	$ 23,322
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions:
Depreciation and amortization	15,631	11,916
Non-cash interest expense and other	1,445	1,104
Loss on debt extinguishment	0	3,113
Change in fair value of contingent consideration	(300)	0
Increase in allowances for doubtful accounts and sales credits	5,315	2,915
Provision for deferred income taxes	17,683	1,768
Share-based compensation	6,551	5,361
Excess tax benefits from share-based compensation	(7,269)	(1,780)
Loss on disposal or sale of fixed assets	3	50
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(46,732)	(19,516)
Accounts receivable, subcontractor	(21,078)	(3,298)
Income taxes receivable	1,008	484
Prepaid expenses	(2,213)	(1,935)
Other current assets	(6,111)	(733)
Other assets	(3,454)	(188)
Accounts payable and accrued expenses	25,808	(4,302)
Accrued compensation and benefits	16,707	8,625
Other liabilities	(4,365)	4,662
Deferred revenue	1,140	(37)
Restricted cash, cash equivalents and investments balance	(5,858)	(9,038)
Net cash provided by operating activities	55,637	22,493
Cash flows from investing activities:
Purchase and development of fixed assets	(21,122)	(14,287)
Equity method investment in Pipeline Health Holdings LLC	(1,000)	(5,000)
Payments to fund deferred compensation plan	(2,250)	(2,174)
Cash paid for acquisitions, net of cash received	(81,097)	0
Cash paid for working capital adjustments for prior year acquisition	(165)	0
Change in restricted cash, cash equivalents and investments balance	0	11,141
Net cash used in investing activities	(105,634)	(10,320)
Cash flows from financing activities:
Capital lease repayments	(4)	(472)
Payments on term loan	(5,625)	(153,370)
Proceeds from term loan	0	150,000
Payments on revolving credit facility	(27,000)	(39,500)
Proceeds from revolving credit facility	84,500	29,500
Payment of financing costs	0	(3,488)
Proceeds from exercise of equity awards	3,663	1,792
Cash paid for shares withheld for taxes	(11,513)	(4,361)
Excess tax benefits from share-based compensation	7,269	1,780
Net cash provided by (used in) financing activities	51,290	(18,119)
Effect of exchange rate changes on cash	42	29
Net increase (decrease) in cash and cash equivalents	1,335	(5,917)
Cash and cash equivalents at beginning of period	13,073	15,580
Cash and cash equivalents at end of period	14,408	9,663
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $173 and $83 capitalized for the nine months ended September 30, 2015 and 2014, respectively)	4,334	3,687
Cash paid for income taxes	20,655	12,732
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash received	26,340	0
Goodwill	46,891	0
Intangible assets	33,592	0
Liabilities assumed	(22,526)	0
Holdback provision	(500)	0
Earn-out liabilities	(2,700)	0
Net cash paid for acquisitions	(81,097)	0
Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses	2,206	3,751
Convertible loan converted to equity method investment in Pipeline Health Holdings LLC	$ 1,000	$ 0

XML

Balance Sheet Details (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Other current assets:
Restricted cash	$ 13,143	$ 9,054
Income taxes receivable	4,195	3,503
Other	7,739	4,643
Other current assets	25,077	17,200
Fixed assets:
Furniture and equipment	21,158	17,761
Software	93,485	78,593
Leasehold improvements	5,224	5,340
Fixed assets, gross	119,867	101,694
Accumulated depreciation and amortization	(74,460)	(68,814)
Fixed assets, net	45,407	32,880
Accounts payable and accrued expenses:
Trade accounts payable	48,109	30,039
Subcontractor payable	53,575	33,474
Professional liability reserve	7,403	7,380
Overdraft	2,548	6,338
Other	1,517	1,762
Accounts payable and accrued expenses	113,152	78,993
Accrued compensation and benefits:
Accrued payroll	32,569	21,857
Accrued bonuses	20,218	15,196
Accrued travel expense	2,868	2,413
Accrued health insurance reserve	2,517	1,871
Accrued workers compensation reserve	7,539	5,830
Deferred compensation	21,968	20,729
Other	813	99
Accrued compensation and benefits	$ 88,492	$ 67,995

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue
Nurse and allied healthcare staffing	$	266,279	$	174,292	$	735,341	$	503,636
Locum tenens staffing	101,755		78,816		285,835		219,996
Physician permanent placement services	14,825		11,476		39,337		32,746
	$	382,859	$	264,584	$	1,060,513	$	756,378
Segment Operating Income
Nurse and allied healthcare staffing	$	40,873	$	21,279	$	108,169	$	63,283
Locum tenens staffing	13,321		8,139		34,142		22,830
Physician permanent placement services	4,555		2,756		11,103		7,074
	58,749		32,174		153,414		93,187
Unallocated corporate overhead	13,817		10,396		38,681		26,958
Depreciation and amortization	5,304		4,086		15,631		11,916
Share-based compensation	2,021		1,791		6,551		5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013		1,433		5,797		7,908
Income before income taxes	$	35,594	$	14,468	$	86,754	$	41,044

XML

Subsequent Events (Details) $ in Thousands	Oct. 05, 2015 USD ($)
Millican Solutions, Inc. [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Cash consideration	$ 4,075

XML

Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2015

Balance Sheet Related Disclosures [Abstract]

Schedule of Supplemental Balance Sheet Disclosures

The consolidated balance sheets detail is as follows as of September 30, 2015 and December 31, 2014:

	September 30, 2015			December 31, 2014
Other current assets:
Restricted cash	$	13,143		$	9,054
Income taxes receivable	4,195			3,503
Other	7,739			4,643
Other current assets	$	25,077		$	17,200
Fixed assets:
Furniture and equipment	$	21,158		$	17,761
Software	93,485			78,593
Leasehold improvements	5,224			5,340
	119,867			101,694
Accumulated depreciation and amortization	(74,460		)	(68,814		)
Fixed assets, net	$	45,407		$	32,880
Accounts payable and accrued expenses:
Trade accounts payable	$	48,109		$	30,039
Subcontractor payable	53,575			33,474
Professional liability reserve	7,403			7,380
Overdraft	2,548			6,338
Other	1,517			1,762
Accounts payable and accrued expenses	$	113,152		$	78,993
Accrued compensation and benefits:
Accrued payroll	$	32,569		$	21,857
Accrued bonuses	20,218			15,196
Accrued travel expense	2,868			2,413
Accrued health insurance reserve	2,517			1,871
Accrued workers compensation reserve	7,539			5,830
Deferred compensation	21,968			20,729
Other	813			99
Accrued compensation and benefits	$	88,492		$	67,995

XML

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Statement of Cash Flows [Abstract]
Interest capitalized	$ 173	$ 83

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 7,460	$ 4,515
Accumulated depreciation	74,460	68,814
Accumulated amortization	$ 50,725	$ 41,963
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	47,694,000	46,639,000
Common stock, shares outstanding	47,694,000	46,639,000

XML

Balance Sheet Details

9 Months Ended

Sep. 30, 2015

Balance Sheet Related Disclosures [Abstract]

BALANCE SHEET DETAILS

BALANCE SHEET DETAILS

The consolidated balance sheets detail is as follows as of September 30, 2015 and December 31, 2014:

	September 30, 2015			December 31, 2014
Other current assets:
Restricted cash	$	13,143		$	9,054
Income taxes receivable	4,195			3,503
Other	7,739			4,643
Other current assets	$	25,077		$	17,200
Fixed assets:
Furniture and equipment	$	21,158		$	17,761
Software	93,485			78,593
Leasehold improvements	5,224			5,340
	119,867			101,694
Accumulated depreciation and amortization	(74,460		)	(68,814		)
Fixed assets, net	$	45,407		$	32,880
Accounts payable and accrued expenses:
Trade accounts payable	$	48,109		$	30,039
Subcontractor payable	53,575			33,474
Professional liability reserve	7,403			7,380
Overdraft	2,548			6,338
Other	1,517			1,762
Accounts payable and accrued expenses	$	113,152		$	78,993
Accrued compensation and benefits:
Accrued payroll	$	32,569		$	21,857
Accrued bonuses	20,218			15,196
Accrued travel expense	2,868			2,413
Accrued health insurance reserve	2,517			1,871
Accrued workers compensation reserve	7,539			5,830
Deferred compensation	21,968			20,729
Other	813			99
Accrued compensation and benefits	$	88,492		$	67,995

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 04, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	AMN HEALTHCARE SERVICES INC
Entity Central Index Key	0001142750
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		47,693,968

XML

Subsequent Events

9 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

On October 5, 2015, the Company completed its acquisition of Millican Solutions, Inc., a physician and executive leadership search firm serving academic medical centers nationwide for $4,075 in cash. The acquisition is intended to enhance the Company’s ability to respond to the specialized leadership needs within academic pediatrics and children’s medical centers and expands the Company’s expertise in serving academic medical centers and teaching hospitals in physician and leadership search.

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Revenue	$ 382,859	$ 264,584	$ 1,060,513	$ 756,378
Cost of revenue	256,850	184,278	722,954	524,957
Gross profit	126,009	80,306	337,559	231,421
Operating expenses:
Selling, general and administrative	83,098	60,319	229,377	170,553
Depreciation and amortization	5,304	4,086	15,631	11,916
Total operating expenses	88,402	64,405	245,008	182,469
Income from operations	37,607	15,901	92,551	48,952
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013	1,433	5,797	7,908
Income before income taxes	35,594	14,468	86,754	41,044
Income tax expense	1,947	5,969	25,028	17,722
Net income	33,647	8,499	61,726	23,322
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Foreign currency translation	54	75	42	29
Unrealized loss on cash flow hedge, net of income taxes	(367)	0	(331)	0
Other comprehensive income (loss):	(313)	75	(289)	29
Comprehensive income	$ 33,334	$ 8,574	$ 61,437	$ 23,351
Net income per common share:
Basic (in dollars per share)	$ 0.71	$ 0.18	$ 1.30	$ 0.50
Diluted (in dollars per share)	$ 0.69	$ 0.18	$ 1.27	$ 0.49
Weighted average common shares outstanding:
Basic (shares)	47,674	46,546	47,466	46,460
Diluted (shares)	48,978	48,122	48,737	47,959

XML

Segment Information

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

The Company has three reportable segments: (1) nurse and allied healthcare staffing, (2) locum tenens staffing, and (3) physician permanent placement services.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue
Nurse and allied healthcare staffing	$	266,279	$	174,292	$	735,341	$	503,636
Locum tenens staffing	101,755		78,816		285,835		219,996
Physician permanent placement services	14,825		11,476		39,337		32,746
	$	382,859	$	264,584	$	1,060,513	$	756,378
Segment Operating Income
Nurse and allied healthcare staffing	$	40,873	$	21,279	$	108,169	$	63,283
Locum tenens staffing	13,321		8,139		34,142		22,830
Physician permanent placement services	4,555		2,756		11,103		7,074
	58,749		32,174		153,414		93,187
Unallocated corporate overhead	13,817		10,396		38,681		26,958
Depreciation and amortization	5,304		4,086		15,631		11,916
Share-based compensation	2,021		1,791		6,551		5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013		1,433		5,797		7,908
Income before income taxes	$	35,594	$	14,468	$	86,754	$	41,044

XML

Net Income Per Common Share

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

NET INCOME PER COMMON SHARE

NET INCOME PER COMMON SHARE

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.

Share-based awards to purchase 286 shares of common stock were not included in the calculation of diluted net income per common share for the three months ended September 30, 2014 because the effect of these instruments was anti-dilutive. Share-based awards to purchase 12 and 344 shares of common stock were not included in the calculation of diluted net income per common share for the nine months ended September 30, 2015 and 2014, respectively, because the effect of these instruments was anti-dilutive.

The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2015 and 2014, respectively:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Net income	$	33,647	$	8,499	$	61,726	$	23,322
Net income per common share - basic	$	0.71	$	0.18	$	1.30	$	0.50
Net income per common share - diluted	$	0.69	$	0.18	$	1.27	$	0.49
Weighted average common shares outstanding - basic	47,674		46,546		47,466		46,460
Plus dilutive effect of potential common shares	1,304		1,576		1,271		1,499
Weighted average common shares outstanding - diluted	48,978		48,122		48,737		47,959

XML

Fair Value Measurement (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities measured at fair value on recurring basis

The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

	Fair Value Measurements as of September 30, 2015
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds	$	5,626	$	5,626	$	—	$	—
Interest rate swap liability	542		—		542		—
Acquisition contingent consideration earn-out liabilities	3,800		—		—		3,800
Total financial assets and liabilities measured at fair value	$	9,968	$	5,626	$	542	$	3,800

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets and liabilities measured at fair value	$	7,026	$	5,626	$	—	$	1,400

Reconciliations of changes in the fair value of contingent consideration liabilities

The following table sets forth reconciliations of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:

	Three months ended September 30,
	2015			2014
Balance as of July 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

	Nine months ended September 30,
	2015			2014
Balance as of January 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.

Revenue Recognition

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client.

Net Income per Common Share

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.

Segment Information

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

Derivative Instruments

The Company recognizes all derivatives on the balance sheet at fair value based on quotes from an independent pricing service. Gains or losses resulting from changes in the values of the arrangement are recorded in other comprehensive income (loss), net of tax, until the hedged item is recognized in earnings. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivative instrument that is used in the hedging transaction is highly effective in offsetting changes in fair values or cash flows of the hedged item. When it is determined that a derivative instrument is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively and recognizes subsequent changes in market value in earnings.

Fair Value of Financial Instruments

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

Assets and Liabilities Measured on a Recurring Basis

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

The Company’s interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap has been measured as of September 30, 2015 in accordance with Level 2 input of the fair value hierarchy using an independent pricing service, which the Company believes is an industry standard model that considers time value, current market and contractual prices for the underlying instrument, volatility factors and other relevant economic measures.

Fair Value of Financial Instruments

The carrying amount of the Company’s notes payable and revolving credit facility approximate their fair value as the instruments’ interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity. The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

XML

Income Taxes

9 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The Company is subject to income taxation in the U.S. and various states and foreign jurisdictions. As of September 30, 2015, the Company is no longer subject to U.S. federal income or payroll tax examinations before 2011. With few exceptions, as of September 30, 2015, the Company is no longer subject to state, local or foreign income tax examinations by tax authorities for tax years before 2006. The Company’s tax years 2007, 2008, 2009 and 2010 had been under audit by the Internal Revenue Service (“IRS”) for several years and, in 2014, the IRS issued the Company its Revenue Agent Report (“RAR”) and an Employment Tax Examination Report (“ETER”). The RAR proposed adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006, resulting from the proposed disallowance of certain per diems paid to the Company’s healthcare professionals, and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2009 and 2010 related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER were mutually exclusive, and contain multiple tax positions, some of which were contrary to each other. The Company filed a Protest Letter for both the RAR and ETER positions in 2014. The Company received a final determination from the IRS in July 2015 on both the RAR adjustments and ETER assessments and the federal audit was settled for $7,200 (including interest) during the third quarter of 2015. As a result, the Company recorded federal income tax benefits of approximately $12,200 during the quarter ended September 30, 2015 and expects to record the state income tax benefits of approximately $1,500 by the quarter ending December 31, 2016, when the various state statutes are projected to lapse.

The IRS had also been conducting a separate audit of the Company’s 2011 and 2012 tax years. The income and employment tax issues addressed in the 2011 and 2012 examination are consistent with the issues raised in the 2007 through 2010 examination. During the quarter ended March 31, 2015, the IRS completed its 2011 and 2012 examination and issued its RAR and ETER to the Company. The proposed adjustments to the Company’s taxable income for 2011 and 2012 and net operating loss carryforwards from 2010 and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2011 and 2012 are related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER for the 2011 and 2012 years are mutually exclusive and contain multiple tax positions, some of which are contrary to each other. The Company has filed a Protest Letter for both the RAR and ETER in April 2015. The Company intends to defend its position. The IRS began an audit of the Company’s 2013 tax year during the quarter ended June 30, 2015. The Company believes its reserves are adequate with respect to these open years.

XML

Derivative Instruments

9 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS

In April 2015, the Company entered into an interest rate swap agreement to minimize its exposure to interest rate fluctuations on $100,000 of its outstanding variable rate debt under its existing term loan facility whereby the Company pays a fixed rate of 0.983% per annum and receives a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into this agreement.

At September 30, 2015, the interest rate swap agreement had a fair value of $(542), which is included in other long-term liabilities in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2015. The Company has formally documented the hedging relationship and accounts for this arrangement as a cash flow hedge. The Company recognizes all derivatives on the balance sheet at fair value based on quotes from an independent pricing service. Gains or losses resulting from changes in the values of the arrangement are recorded in other comprehensive income (loss), net of tax, until the hedged item is recognized in earnings. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivative instrument that is used in the hedging transaction is highly effective in offsetting changes in fair values or cash flows of the hedged item. When it is determined that a derivative instrument is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively and recognizes subsequent changes in market value in earnings.

XML

Fair Value Measurement

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT

The Company’s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2 and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 4 - Fair Value Measurement” of the 2014 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2015, except for the new interest rate swap agreement entered into in April 2015.

Assets and Liabilities Measured on a Recurring Basis

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

The Company’s interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap has been measured as of September 30, 2015 in accordance with Level 2 input of the fair value hierarchy using an independent pricing service, which the Company believes is an industry standard model that considers time value, current market and contractual prices for the underlying instrument, volatility factors and other relevant economic measures. The valuation also consider credit risk adjustments that are necessary to reflect the probability of default by the counterparty or the Company, which are considered Level 3 inputs; however, as of September 30, 2015, the credit risk adjustments, including nonperformance risk, were considered insignificant to the total fair value of the interest rate swaps.

The Company has an obligation to pay earn-out consideration of up to $8,500 to the selling equity holders if Avantas meets certain future financial metrics for the 12-month period ending June 30, 2016. The Company also has an obligation to pay earn-out consideration of up to $4,000 to the selling shareholders if TFS meets certain future financial metrics for calendar years 2015 and 2016. The earn-out liabilities in connection with both acquisitions were estimated based on estimated cash flows determined using the probability-weighted average of possible outcomes that would occur should certain financial metrics be reached. As there is no market data available to use in valuing the contingent consideration, the Company developed its own assumptions related to the future financial performance of Avantas and TFS to estimate the fair value of the liabilities. As such, the contingent consideration liabilities are classified within Level 3.

In connection with estimating the fair value of the contingent consideration for Avantas, the Company estimates the weighted probability of Avantas earning each of the five specified tiered earn-out amounts of $0, $1,500, $3,500, $5,500 and $8,500, which are each tied to the financial performance of Avantas for the 12-month period ending June 30, 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015.

In connection with estimating the fair value of the contingent consideration for TFS, the Company estimates the weighted probability of TFS earning each of the three specified tiered earn-out amounts of $0, $500, and $1,000, which are each tied to the financial performance of TFS for calendar year 2015 and each of the six specified tiered earn-out amounts of $0, $1,000, $1,500, $2,000, $2,500 and $3,000, which are each tied to the financial performance of TFS for calendar year 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value.

The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

	Fair Value Measurements as of September 30, 2015
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds	$	5,626	$	5,626	$	—	$	—
Interest rate swap liability	542		—		542		—
Acquisition contingent consideration earn-out liabilities	3,800		—		—		3,800
Total financial assets and liabilities measured at fair value	$	9,968	$	5,626	$	542	$	3,800

	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets and liabilities measured at fair value	$	7,026	$	5,626	$	—	$	1,400

Level 3 Information

The following table sets forth reconciliations of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:

	Three months ended September 30,
	2015			2014
Balance as of July 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

	Nine months ended September 30,
	2015			2014
Balance as of January 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

There were no triggering events identified and no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets or equity method investment during the nine months ended September 30, 2015 and 2014.

Fair Value of Financial Instruments

The carrying amount of the Company’s notes payable and revolving credit facility approximate their fair value as the instruments’ interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity. The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

(a) Legal

From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of its clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. With regards to outstanding loss contingencies as of September 30, 2015, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows.

(b) Leases

On January 26, 2015, the Company entered into a 10-year operating lease agreement for office space in Dallas, Texas that replaced its current operating lease agreement for its Irving, Texas offices, which expired in August 2015. Base rent payments under the new lease agreement began in September 2015 and the total estimated base rent payments will be approximately $23,956 over the life of the lease, which is ten years. The rent payments have been included in the total minimum lease payment table set forth in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 12(b) - Commitments and Contingencies - Leases” of the Company’s 2014 Annual Report.

XML

Commitments and Contingencies - Leases (Details) $ in Thousands	Jan. 26, 2015 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Operating lease agreement term	10 years
Total minimum lease payments	$ 23,956

XML

Net Income Per Common Share (Tables)

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Computation of basic and diluted net income per common share

The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2015 and 2014, respectively:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Net income	$	33,647	$	8,499	$	61,726	$	23,322
Net income per common share - basic	$	0.71	$	0.18	$	1.30	$	0.50
Net income per common share - diluted	$	0.69	$	0.18	$	1.27	$	0.49
Weighted average common shares outstanding - basic	47,674		46,546		47,466		46,460
Plus dilutive effect of potential common shares	1,304		1,576		1,271		1,499
Weighted average common shares outstanding - diluted	48,978		48,122		48,737		47,959

XML

Revenue Recognition (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Revenue Recognition [Abstract]
Payables to subcontractor	$ 53,575	$ 33,474

XML

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Loss on debt extinguishment	$ 0	$ 0	$ 3,113

XML

Revenue Recognition

9 Months Ended

Sep. 30, 2015

Revenue Recognition [Abstract]

REVENUE RECOGNITION

REVENUE RECOGNITION

Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $53,575 and $33,474 were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of September 30, 2015 and the audited consolidated balance sheet as of December 31, 2014, respectively.

XML

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Common stock excluded from calculation of EPS		286	12	344
Computation of basic and diluted net income per common share
Net income	$ 33,647	$ 8,499	$ 61,726	$ 23,322
Net income per common share - basic (in dollars per share)	$ 0.71	$ 0.18	$ 1.30	$ 0.50
Net income per common share - diluted (in dollars per share)	$ 0.69	$ 0.18	$ 1.27	$ 0.49
Weighted average common shares outstanding - basic	47,674	46,546	47,466	46,460
Plus dilutive effect of potential common shares	1,304	1,576	1,271	1,499
Weighted average common shares outstanding - diluted	48,978	48,122	48,737	47,959

XML

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Summary of Fair Value and Useful Life of Each Intangible Asset Acquired

The following table summarizes the fair value and useful life of each intangible asset acquired:

		Fair Value		Useful Life
				(in years)
Identifiable intangible assets
	Tradenames and Trademarks	$	8,100	3 - 15
	Customer Relationships	17,600		10 - 15
	Staffing Database	2,600		5
	Acquired Technologies	1,700		8
	Non-compete agreements	219		2
		$	30,219

Business Acquisition, Pro Forma Information

The following summary presents unaudited pro forma consolidated results of operations of the Company for the three and nine months ended September 30, 2015 and 2014 as if the OH acquisition described above had occurred on January 1, 2014. The following unaudited pro forma financial information gives effect to certain adjustments, including the reduction in compensation expense related to non-recurring executive salary expense, acquisition-related costs and the amortization of acquired intangible assets. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue	$	382,859	$	293,072	$	1,062,798	$	838,109
Net income	$	34,350	$	9,091	$	63,513	$	24,088
Net income per common share:
Basic	$	0.72	$	0.20	$	1.34	$	0.52
Diluted	$	0.70	$	0.19	$	1.30	$	0.50